Pnv-dha
ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, cyanocobalamin, calcium, ferrous fumarate, magnesium, doconexent · Capsule, Gelatin Coated · Oral
Uses
INDICATIONS: PNV-DHA is a multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.
Dosage and administration
DOSAGE AND ADMINISTRATION: Before, during and/or after pregnancy, one softgel daily or as directed by a physician.
Contraindications
CONTRAINDICATIONS: PNV-DHA is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Precautions
PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B 12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
Side effects
ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Description
DESCRIPTION: PNV-DHA is a prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel. Each softgel is cobalt blue in color, opaque and imprinted with “BP 321” on one side and blank on the other. PNV-DHA can also be beneficial in improving the nutritional status of women prior to conception. Supplement Facts Panel PNV-DHA contains fish oil and soy. OTHER INGREDIENTS: Beeswax, soy lecithin and vegetable shortening. Coating contains: Bovine gelatin, FD&C Blue No. 1, FD&C Red No. 3, glycerin, purified water and titanium dioxide. Contains Soy. INDICATIONS: PNV-DHA is a multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. CONTRAINDICATIONS: PNV-DHA is contraindicated in patients with a known hypersensitivity to any of the ingredients.
How supplied
HOW SUPPLIED: Bottles of 30 softgels (42192-321-30). The listed product number is not a National Code. Instead, Acella Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems. STORAGE: Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature.]
Label text from the FDA structured product label by Acella Pharmaceuticals, LLC (revised Jul 23, 2026). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Ascorbic Acid in 2 products
- Cholecalciferol in 2 products
- .alpha.-tocopherol Acetate, Dl- in 2 products
- Pyridoxine in 2 products
- Folic Acid in 2 products
- Calcium in 2 products
- Ferrous Fumarate in 2 products
- Doconexent in 2 products
- Cyanocobalamin in 1 product
- Magnesium in 1 product
Pnv-dha NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 42192-321 | Ascorbic Acid 85 [iU]/1; Cholecalciferol 200 [iU]/1; .alpha.-tocopherol Acetate, Dl- 10 [iU]/1; Pyridoxine 25 [iU]/1;… Capsule, Gelatin Coated | Acella Pharmaceuticals, LLC | UNAPPROVED DRUG OTHER |
| 42192-323 | Ascorbic Acid 28 mg/1; Calcium 160 mg/1; Ferrous Fumarate 27 mg/1; Cholecalciferol 400 [iU]/1; .alpha.-tocopherol… Capsule, Gelatin Coated | Acella Pharmaceuticals, LLC | UNAPPROVED DRUG OTHER |
Frequently asked questions
What is Pnv-dha used for?
INDICATIONS: PNV-DHA is a multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.
What are the side effects of Pnv-dha?
ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid. See the full label for the complete list.
Who makes Pnv-dha?
Pnv-dha is listed by 1 labeler in the FDA NDC directory, including Acella Pharmaceuticals, LLC.